DK3536346T3 - PET tracer til afbildning af neuroendocrine tumorer - Google Patents
PET tracer til afbildning af neuroendocrine tumorer Download PDFInfo
- Publication number
- DK3536346T3 DK3536346T3 DK19164889.8T DK19164889T DK3536346T3 DK 3536346 T3 DK3536346 T3 DK 3536346T3 DK 19164889 T DK19164889 T DK 19164889T DK 3536346 T3 DK3536346 T3 DK 3536346T3
- Authority
- DK
- Denmark
- Prior art keywords
- neuroendocrine tumors
- pet tracer
- imaging neuroendocrine
- imaging
- tracer
- Prior art date
Links
- 238000003384 imaging method Methods 0.000 title 1
- 201000011519 neuroendocrine tumor Diseases 0.000 title 1
- 239000000700 radioactive tracer Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nuclear Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201100654 | 2011-08-31 | ||
| EP12828526.9A EP2750717B1 (en) | 2011-08-31 | 2012-08-23 | Pet tracer for imaging of neuroendocrine tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3536346T3 true DK3536346T3 (da) | 2021-01-25 |
Family
ID=47755353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19164889.8T DK3536346T3 (da) | 2011-08-31 | 2012-08-23 | PET tracer til afbildning af neuroendocrine tumorer |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10159759B2 (da) |
| EP (2) | EP2750717B1 (da) |
| DK (1) | DK3536346T3 (da) |
| ES (2) | ES2732823T3 (da) |
| HU (2) | HUE044625T2 (da) |
| PL (2) | PL2750717T3 (da) |
| WO (1) | WO2013029616A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2750717B1 (en) * | 2011-08-31 | 2019-03-27 | Somscan ApS | Pet tracer for imaging of neuroendocrine tumors |
| JP2015532636A (ja) * | 2012-05-08 | 2015-11-12 | リグスホスピタレト | 部位特異的ｕＰＡＲ標的化のための１７７−Ｌｕ標識ペプチド |
| GB201219403D0 (en) * | 2012-10-29 | 2012-12-12 | Uni I Olso | Method for improved estimation of tracer uptake in physiological image volumes |
| ES2972124T3 (es) * | 2012-12-03 | 2024-06-11 | Curasight As | Péptidos marcados con un radionúclido que emite positrones para obtención de imágenes de PET del uPAR humana |
| WO2014169073A1 (en) | 2013-04-09 | 2014-10-16 | Massachusetts Institute Of Technology | Drug delivery polymer and uses thereof |
| DK3193945T3 (da) * | 2014-09-17 | 2020-11-16 | Fluoguide As | Upar-målrettende peptid til anvendelse ved peroperativ optisk billeddannelse af invasiv cancer |
| HRP20231458T1 (hr) * | 2017-01-12 | 2024-05-10 | Radiomedix Inc. | Liječenje stanica raka koje prekomjerno eksprimiraju receptore za somatostatin primjenom derivata oktreotida keliranih sa radioizotopima |
| CN112423744A (zh) | 2018-04-11 | 2021-02-26 | 透明医药有限公司 | 用于放射疗法和诊断成像的制剂和试剂盒 |
| WO2019240884A2 (en) | 2018-04-27 | 2019-12-19 | University Of Iowa Research Foundation | Compositions for chelating metals at low temperatures |
| TWI878344B (zh) | 2019-09-17 | 2025-04-01 | 瑞士商諾華公司 | 放射性標記grpr拮抗劑之方法及其套組 |
| CA3166142A1 (en) * | 2020-01-29 | 2021-08-05 | Dongyoul Lee | Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers |
| IL297323A (en) | 2020-04-29 | 2022-12-01 | Novartis Ag | Methods for radiological labeling of psma-binding ligands and their kits |
| TWI905175B (zh) | 2020-04-29 | 2025-11-21 | 瑞士商諾華公司 | 放射性標記psma結合配位體的方法及其套組 |
| AU2021336987A1 (en) * | 2020-09-03 | 2023-04-06 | Curium Us Llc | Radiolabeling and formulation for scale up of 64Cu-dotatate |
| US11541134B1 (en) | 2021-08-02 | 2023-01-03 | Rayzebio, Inc. | Stabilized compositions of radionuclides and uses thereof |
| EP4197561A1 (en) * | 2021-12-15 | 2023-06-21 | Curasight A/S | Urokinase-type plasminogen activator receptor (upar)-pet/ct in neuroendocrine neoplams |
| KR20250073273A (ko) | 2022-09-23 | 2025-05-27 | 누클리디움 아게 | 고순도 구리 방사성 의약 조성물 및 이의 진단 및 치료 용도 |
| TW202426433A (zh) | 2022-09-23 | 2024-07-01 | 瑞士商紐利迪姆股份公司 | 成纖維細胞活化蛋白（ｆａｐ）抑制劑、ｆａｐ結合物及其診斷與治療用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7122622B2 (en) * | 2002-04-16 | 2006-10-17 | Biosynthema Inc. | Peptide compounds having improved binding affinity to somatostatin receptors |
| US20070025910A1 (en) | 2005-07-29 | 2007-02-01 | Norenberg Jeffrey P | Anticancer therapy |
| EP2750717B1 (en) * | 2011-08-31 | 2019-03-27 | Somscan ApS | Pet tracer for imaging of neuroendocrine tumors |
-
2012
- 2012-08-23 EP EP12828526.9A patent/EP2750717B1/en active Active
- 2012-08-23 PL PL12828526T patent/PL2750717T3/pl unknown
- 2012-08-23 HU HUE12828526 patent/HUE044625T2/hu unknown
- 2012-08-23 ES ES12828526T patent/ES2732823T3/es active Active
- 2012-08-23 HU HUE19164889A patent/HUE052723T2/hu unknown
- 2012-08-23 PL PL19164889T patent/PL3536346T3/pl unknown
- 2012-08-23 EP EP19164889.8A patent/EP3536346B1/en active Active
- 2012-08-23 DK DK19164889.8T patent/DK3536346T3/da active
- 2012-08-23 ES ES19164889T patent/ES2842998T3/es active Active
- 2012-08-23 US US14/241,958 patent/US10159759B2/en active Active
- 2012-08-23 WO PCT/DK2012/050305 patent/WO2013029616A1/en not_active Ceased
-
2018
- 2018-11-02 US US16/179,453 patent/US10383961B2/en active Active
-
2019
- 2019-06-27 US US16/454,631 patent/US11160888B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2842998T3 (es) | 2021-07-15 |
| PL2750717T3 (pl) | 2019-11-29 |
| EP2750717B1 (en) | 2019-03-27 |
| EP2750717A1 (en) | 2014-07-09 |
| HUE052723T2 (hu) | 2021-05-28 |
| US11160888B2 (en) | 2021-11-02 |
| ES2732823T3 (es) | 2019-11-26 |
| EP3536346A1 (en) | 2019-09-11 |
| WO2013029616A1 (en) | 2013-03-07 |
| US10383961B2 (en) | 2019-08-20 |
| US20190321497A1 (en) | 2019-10-24 |
| US20190083664A1 (en) | 2019-03-21 |
| US10159759B2 (en) | 2018-12-25 |
| PL3536346T3 (pl) | 2021-07-19 |
| EP2750717A4 (en) | 2015-03-04 |
| HUE044625T2 (hu) | 2019-11-28 |
| US20140341807A1 (en) | 2014-11-20 |
| EP3536346B1 (en) | 2020-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3536346T3 (da) | PET tracer til afbildning af neuroendocrine tumorer | |
| EP3902258C0 (en) | REFERENCE IMAGE SIGNALING | |
| EP2825902A4 (en) | REPAIR OF GPS DATA | |
| HUE039849T2 (hu) | CD70 elleni ellenanyagok | |
| DK2659675T3 (da) | Fremgangsmåde for billedsegmentering under anvendelse af søjler | |
| EP2737089A4 (en) | LIBRARY CHARACTERIZATION BY DIGITAL TEST | |
| BR112013010351A2 (pt) | aparelho de formação de imagem | |
| EP2799911A4 (en) | RADIATION DETECTOR | |
| PT2919581T (pt) | Instalação de aquacultura de mar alto | |
| EP4092959C0 (en) | BILLING FOR A DATA SERVICE | |
| DK2876447T3 (da) | Fremgangsmåde til detektering af cancer | |
| EP2636359A4 (en) | IMAGING DEVICE | |
| BR112014001383A2 (pt) | aparelho de formação de imagem | |
| EP2735262A4 (en) | Imaging device | |
| DK2531526T3 (da) | Fremgangsmåde til opnåelse af antistoffer | |
| DK3041576T3 (da) | Fremgangsmåder til at detektere nyresygdom | |
| BR112014000928A2 (pt) | aparelho de aquisição de informações de objeto | |
| HUE056971T2 (hu) | Eljárás képek dekódolására | |
| DK3402201T3 (da) | Fremgangsmåde til dekodning af et billede | |
| EP2704416A4 (en) | Imaging device | |
| EP2726839A4 (en) | SAMPLERS | |
| DK2734834T3 (da) | Røntgenbilleddannelse | |
| EP2706946A4 (en) | Positioning marker | |
| BR112013023694A2 (pt) | método de navegação de imagem 3d | |
| FI20125179L (fi) | Menetelmä kelluttamiseksi |